articleTop 1% cited

Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes

Journal of Clinical Epidemiology · 2012 · Vol. 65(9) · pp. 989–995

Danijela Gnjidic✉(Concord Repatriation General Hospital)Sarah N. Hilmer(University of Sydney)Fiona Blyth(Sax Institute)Vasi Naganathan(University of Sydney)Louise M. Waite(University of Sydney)Markus J. Seibel(Anzac Research Institute)Andrew J. McLachlan(University of Sydney)Robert G. Cumming(University of Sydney)David J. Handelsman(Concord Repatriation General Hospital)David G. Le Couteur(Concord Repatriation General Hospital)

View via DOI Publisher page

Pharmaceutical Practices and Patient Outcomes Health Systems, Economic Evaluations, Quality of Life Blood Pressure and Hypertension StudiesPolypharmacyMedicineYouden's J statisticConfidence intervalOdds ratioReceiver operating characteristicCutoffAdverse effectGeriatricsGerontology

MeSH terms

Accidental FallsAgedAged, 80 and overCognition DisordersDisability EvaluationHumansMaleROC CurveGeriatric AssessmentOdds RatioSurvival AnalysisFrail ElderlyOutcome Assessment, Health CarePolypharmacyPrescription Drugs

Citations

1,153

FWCI

20.36

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Health Outcomes Associated with Polypharmacy in Community‐Dwelling Older Adults: A Systematic Review